An RBP4 promoter polymorphism increases risk of type 2 diabetes.
about
Vitamins and type 2 diabetes mellitusNovel role for retinol-binding protein 4 in the regulation of blood pressure.Serum level and polymorphisms of retinol-binding protein-4 and risk for gestational diabetes mellitus: a meta-analysisRetinol binding protein 4 in relation to diet, inflammation, immunity, and cardiovascular diseasesLiver retinol transporter and receptor for serum retinol-binding protein (RBP4)RBP4 activates antigen-presenting cells, leading to adipose tissue inflammation and systemic insulin resistance.Effects of PPARγ and RBP4 gene variants on metabolic syndrome in HIV-infected patients with anti-retroviral therapyA genetic polymorphism in RBP4 is associated with coronary artery disease.Adipokines as drug targets in diabetes and underlying disturbances.Transthyretin Antisense Oligonucleotides Lower Circulating RBP4 Levels and Improve Insulin Sensitivity in Obese Mice.Quantitative measurement of full-length and C-terminal proteolyzed RBP4 in serum of normal and insulin-resistant humans using a novel mass spectrometry immunoassayTransgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism.Retinol-binding protein 4 inhibits insulin signaling in adipocytes by inducing proinflammatory cytokines in macrophages through a c-Jun N-terminal kinase- and toll-like receptor 4-dependent and retinol-independent mechanism.Antigen Presentation and T-Cell Activation Are Critical for RBP4-Induced Insulin Resistance.Plasma retinol-binding protein 4 (RBP4) levels and risk of coronary heart disease: a prospective analysis among women in the nurses' health study.RBP4 variants are significantly associated with plasma RBP4 levels and hypertriglyceridemia risk in Chinese Hans.Long-term Fenretinide treatment prevents high-fat diet-induced obesity, insulin resistance, and hepatic steatosisRBP4 gene variants are associated with insulin resistance in women with previous gestational diabetesDownregulation of STRA6 in adipocytes and adipose stromovascular fraction in obesity and effects of adipocyte-specific STRA6 knockdown in vivo.Physiological insights gained from gene expression analysis in obesity and diabetes.Adipose tissue regulates insulin sensitivity: role of adipogenesis, de novo lipogenesis and novel lipids.Plasma Retinol-Binding Protein 4 Levels and the Risk of Ischemic Stroke among Women.Association of RBP4 genetic variants with childhood obesity and cardiovascular risk factors.Association of RBP4 gene variants and serum HDL cholesterol levels in the Newfoundland population.QTL for several metabolic traits map to loci controlling growth and body composition in an F2 intercross between high- and low-growth chicken lines.Hepatocytes Are the Principal Source of Circulating RBP4 in Mice.The Role of Microglia in Diabetic Retinopathy: Inflammation, Microvasculature Defects and Neurodegeneration.The retinol-binding protein receptor STRA6 regulates diurnal insulin responses.Development of a mouse IgA monoclonal antibody-based enzyme-linked immunosorbent sandwich assay for the analyses of RBP4.Changes in Liver Gene Expression and Plasma Concentration of Rbp4, Fetuin-A, and Fgf21 in Sprague-Dawley Rats Subjected to Different Dietary Interventions and Bariatric Surgery
P2860
Q27022122-5C70B368-F84F-4242-80C6-3953CF451F37Q27318848-A0DA0882-E70A-4874-8558-8FCBF0819DBBQ28078556-524AD5D3-24FB-4EC4-834F-2CB537E8A7AEQ28082224-7C9776E9-C3BF-4D8E-9AD6-8CD04F25C58AQ28512269-FA732E54-84BD-41E7-AF36-B2E1DEF70E35Q33831780-9F9923A0-9A0B-4A4B-A7B0-451A8F14E839Q34474050-4E879A7E-76BE-4CBB-8178-77FC014AE3ADQ34834337-EBD3071C-F413-429F-9D9A-9E7CA717EBE6Q35415815-788D613E-5AB1-491E-90F6-DA55315F2209Q35532291-934457BF-367A-46B9-A03D-38A8320DB815Q35762679-2384EFFE-ACE6-4B44-8155-61CC7CDF2649Q35868411-C1F7298F-4439-4C3A-AC62-84A0CF8CBF76Q35943971-FD10047D-71C6-4846-861A-CF9454BE1A11Q36820735-6CF70D3D-D1DB-4409-8CC5-9FE729F582FDQ37090547-C7457DDE-7414-45A0-BB96-66143EDC3E83Q37222431-A5892ED5-237E-4B80-A2B4-AEA00F2954A7Q37474455-8AC46F8E-722E-4320-8937-668299B3BF6EQ37602588-7D5113DB-ABE9-4957-BBC5-76D277CB397EQ37643950-7FCFB259-C8BC-42EC-8770-8C058F86E8F4Q37736477-530AFCDB-70B9-4ABB-B557-67E7721BAA5DQ38809397-13CF971B-C218-45FD-9C60-751FE7E93668Q40049689-41E950C3-13BA-4CBA-8AB0-E3EADA13B3CEQ40269808-C2EA0E5F-7C41-40EC-8AF8-8BD92E1A8A98Q43247468-F20FDCC5-9030-457B-A154-CE5061397E11Q45966992-3E895A8D-3BC7-4125-BA06-8EB6D540CAEFQ48037684-39EFD1CF-87F5-4214-B088-9153384E62C8Q48308877-C7E81E27-359E-4A18-B36C-BB1BB51B007CQ48364108-15D686EA-F2D1-456C-A40C-8560C7BFFA87Q49237590-E0E64A98-8EB6-4F68-B469-AD4D99D6F176Q58772800-089F6B4C-579E-42DA-934B-DF496ABA18DC
P2860
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@ast
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@en
type
label
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@ast
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@en
prefLabel
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@ast
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@en
P2093
P2860
P50
P1433
P1476
An RBP4 promoter polymorphism increases risk of type 2 diabetes.
@en
P2093
J C Witteman
M C Zillikens
M van Hoek
P2860
P2888
P304
P356
10.1007/S00125-008-1042-8
P577
2008-05-22T00:00:00Z